PMC:7441788 / 3535-3733 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T11","span":{"begin":75,"end":79},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T40","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0007256"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T26","span":{"begin":60,"end":65},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T27","span":{"begin":75,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0000031"},{"id":"T28","span":{"begin":86,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0051864"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T43","span":{"begin":6,"end":8},"obj":"Chemical"}],"attributes":[{"id":"A43","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T27","span":{"begin":6,"end":8},"obj":"Chemical"}],"attributes":[{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T37","span":{"begin":17,"end":25},"obj":"Species"},{"id":"T38","span":{"begin":30,"end":39},"obj":"Species"},{"id":"T39","span":{"begin":60,"end":65},"obj":"Species"}],"attributes":[{"id":"A37","pred":"ncbi_taxonomy_id","subj":"T37","obj":"NCBItxid:1335626"},{"id":"A38","pred":"ncbi_taxonomy_id","subj":"T38","obj":"NCBItxid:11137"},{"id":"A39","pred":"ncbi_taxonomy_id","subj":"T39","obj":"NCBItxid:9606"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"154","span":{"begin":180,"end":182},"obj":"Gene"},{"id":"158","span":{"begin":163,"end":165},"obj":"Gene"},{"id":"159","span":{"begin":17,"end":25},"obj":"Species"},{"id":"160","span":{"begin":30,"end":39},"obj":"Species"},{"id":"161","span":{"begin":60,"end":65},"obj":"Species"},{"id":"167","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"170","span":{"begin":86,"end":91},"obj":"CellLine"}],"attributes":[{"id":"A154","pred":"pubann:denotes","subj":"154","obj":"Gene:56925"},{"id":"A158","pred":"pubann:denotes","subj":"158","obj":"Gene:56925"},{"id":"A159","pred":"pubann:denotes","subj":"159","obj":"Tax:1335626"},{"id":"A160","pred":"pubann:denotes","subj":"160","obj":"Tax:11137"},{"id":"A161","pred":"pubann:denotes","subj":"161","obj":"Tax:9606"},{"id":"A167","pred":"pubann:denotes","subj":"167","obj":"MESH:D006528"},{"id":"A170","pred":"pubann:denotes","subj":"170","obj":"CVCL:0336"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T21","span":{"begin":75,"end":79},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T11","span":{"begin":75,"end":79},"obj":"Body_part"}],"attributes":[{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T34","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0007256"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}

{"project":"LitCovid-PubTator","denotations":[{"id":"154","span":{"begin":180,"end":182},"obj":"Gene"},{"id":"158","span":{"begin":163,"end":165},"obj":"Gene"},{"id":"159","span":{"begin":17,"end":25},"obj":"Species"},{"id":"160","span":{"begin":30,"end":39},"obj":"Species"},{"id":"161","span":{"begin":60,"end":65},"obj":"Species"},{"id":"167","span":{"begin":66,"end":74},"obj":"Disease"},{"id":"170","span":{"begin":86,"end":91},"obj":"CellLine"}],"attributes":[{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"Gene:56925"},{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"Gene:56925"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Tax:1335626"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Tax:11137"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Tax:9606"},{"id":"A167","pred":"tao:has_database_id","subj":"167","obj":"MESH:D006528"},{"id":"A170","pred":"tao:has_database_id","subj":"170","obj":"CVCL:0336"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ty of CQ against MERS-CoV and HCoV-229E was assessed in the human hepatoma cell line (Huh-7) and found that the 50% effective concentrations (EC50) were 3.0(±1.1) μM and 3.3(±1.2) μM, the 50% cytoto"}